RGPD8

gene
On this page

Also known as RanBP2alpha

Summary

RGPD8 (RANBP2 like and GRIP domain containing 8, HGNC:9849) is a protein-coding gene on chromosome 2q14.1, encoding RANBP2-like and GRIP domain-containing protein 8 (O14715).

Predicted to enable small GTPase binding activity. Predicted to contribute to GTPase activator activity. Predicted to be involved in NLS-bearing protein import into nucleus. Predicted to be part of nuclear pore. Predicted to be active in cytoplasm.

Source: NCBI Gene 727851 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 200 total — 2 pathogenic
  • MANE Select transcript: NM_001164463

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:9849
Approved symbolRGPD8
NameRANBP2 like and GRIP domain containing 8
Location2q14.1
Locus typegene with protein product
StatusApproved
AliasesRanBP2alpha
Ensembl geneENSG00000169629
Ensembl biotypeprotein_coding
OMIM602752
Entrez727851

Gene structure

Transcript identifiers

Ensembl transcripts: 8 — 5 protein_coding, 2 retained_intron, 1 nonsense_mediated_decay

ENST00000302558, ENST00000330575, ENST00000409750, ENST00000471422, ENST00000482903, ENST00000496537, ENST00000522286, ENST00000929966

RefSeq mRNA: 1 — MANE Select: NM_001164463 NM_001164463

CCDS: CCDS46394

Canonical transcript exons

ENST00000302558 — 23 exons

ExonStartEnd
ENSE00002439741112421960112422112
ENSE00002447820112417193112417338
ENSE00002457769112378053112378254
ENSE00002459041112422548112422659
ENSE00002461552112380824112380963
ENSE00002467742112433382112433645
ENSE00002480479112401117112401240
ENSE00002483202112417684112417914
ENSE00002517895112388024112390247
ENSE00002523283112403966112404175
ENSE00003533182112424240112424307
ENSE00003564739112400036112400194
ENSE00003586760112406297112406384
ENSE00003604039112394618112394753
ENSE00003610246112390975112391069
ENSE00003624035112401667112401848
ENSE00003642132112399632112399769
ENSE00003653293112397922112398005
ENSE00003664074112412431112412626
ENSE00003674443112398099112398278
ENSE00003689127112401408112401583
ENSE00003692916112399223112399369
ENSE00003894210112368369112370212

Expression profiles

Bgee: expression breadth ubiquitous, 134 present calls, max score 89.83.

FANTOM5 (CAGE): breadth broad, TPM avg 1.1300 / max 26.2194, expressed in 570 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
2023351.1300570

Top tissues by expression

134 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047389.83gold quality
calcaneal tendonUBERON:000370188.49gold quality
sural nerveUBERON:001548883.96gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099183.66gold quality
right testisUBERON:000453482.97gold quality
testisUBERON:000047382.95gold quality
bone marrow cellCL:000209282.02gold quality
left testisUBERON:000453381.95gold quality
bone marrowUBERON:000237181.55gold quality
adrenal tissueUBERON:001830380.47gold quality
tonsilUBERON:000237279.13gold quality
ventricular zoneUBERON:000305378.89gold quality
primary visual cortexUBERON:000243678.52gold quality
mucosa of stomachUBERON:000119978.36gold quality
right coronary arteryUBERON:000162578.29gold quality
adenohypophysisUBERON:000219677.89gold quality
pituitary glandUBERON:000000777.58gold quality
islet of LangerhansUBERON:000000677.52gold quality
body of pancreasUBERON:000115077.12gold quality
thoracic mammary glandUBERON:000520077.07gold quality
endometriumUBERON:000129577.02gold quality
pancreasUBERON:000126477.00gold quality
superior frontal gyrusUBERON:000266176.99gold quality
cortical plateUBERON:000534376.65gold quality
subcutaneous adipose tissueUBERON:000219076.48gold quality
thoracic aortaUBERON:000151576.35gold quality
ascending aortaUBERON:000149676.32gold quality
cerebellar cortexUBERON:000212976.10gold quality
cerebellar hemisphereUBERON:000224576.07gold quality
descending thoracic aortaUBERON:000234576.07gold quality

Single-cell (SCXA)

Detected in 2 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-MTAB-7606no37.80
E-ANND-3no3.71

Regulation

Is transcription factor: no

miRNA regulators (miRDB)

123 targeting RGPD8, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-12118100.0065.881270
HSA-MIR-513A-5P100.0069.772465
HSA-MIR-450A-1-3P100.0069.331837
HSA-MIR-4262100.0073.263931
HSA-MIR-340-5P100.0072.504437
HSA-MIR-126-5P100.0072.713180
HSA-MIR-4425100.0067.591049
HSA-MIR-5692A100.0074.406850
HSA-MIR-186-5P99.9970.833707
HSA-MIR-548AW99.9972.573559
HSA-MIR-181A-5P99.9972.962995
HSA-MIR-181B-5P99.9972.972996
HSA-MIR-181C-5P99.9972.952996
HSA-MIR-181D-5P99.9973.042997
HSA-MIR-450099.9972.722367
HSA-MIR-118499.9968.191458
HSA-MIR-27A-3P99.9872.132955
HSA-MIR-27B-3P99.9872.132955
HSA-MIR-998599.9872.112939
HSA-MIR-6891-5P99.9866.531372
HSA-MIR-3173-3P99.9866.491217
HSA-MIR-103A-3P99.9869.141595
HSA-MIR-10799.9869.141595
HSA-LET-7F-2-3P99.9870.982588
HSA-MIR-1185-1-3P99.9871.042593
HSA-MIR-1185-2-3P99.9871.042593
HSA-MIR-539-3P99.9870.741616
HSA-MIR-485-3P99.9870.681585
HSA-LET-7A-5P99.9872.291790

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
danio_rerioranbp3aENSDARG00000008727
drosophila_melanogasterRanBP3FBGN0039110

Paralogs (10): RGPD5 (ENSG00000015568), RANBP3 (ENSG00000031823), RANBP1 (ENSG00000099901), RGPD3 (ENSG00000153165), RANBP2 (ENSG00000153201), RANBP3L (ENSG00000164188), RGPD6 (ENSG00000183054), RGPD2 (ENSG00000185304), RGPD1 (ENSG00000187627), RGPD4 (ENSG00000196862)

Protein

Protein identifiers

RANBP2-like and GRIP domain-containing protein 8O14715 (reviewed: O14715)

Alternative names: Ran-binding protein 2-like 3

All UniProt accessions (5): C9J6W1, O14715, F8W705, H0YBN8, J3KQ37

UniProt curated annotations — full annotation on UniProt →

Subunit / interactions. Interacts with GTP-bound ARL1.

Miscellaneous. One of the 8 copies of RANBP2 clustered close to the chromosome 2 centromere.

RefSeq proteins (1): NP_001157935* (*=MANE)

Domains & families (InterPro)

IDNameType
IPR000156Ran_bind_domDomain
IPR000237GRIP_domDomain
IPR011990TPR-like_helical_dom_sfHomologous_superfamily
IPR011993PH-like_dom_sfHomologous_superfamily
IPR019734TPR_rptRepeat
IPR032023GCC2_Rab_bindDomain
IPR045255RanBP1-likeFamily

Pfam: PF00638, PF01465, PF16704

UniProt features (23 total): region of interest 5, compositionally biased region 5, sequence conflict 4, repeat 3, domain 3, modified residue 2, chain 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-O14715-F167.280.28

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (2): 19, 21

Function

Pathways and Gene Ontology

Reactome pathways

0 pathways

MSigDB gene sets: 62 (showing top): GOBP_INTRACELLULAR_PROTEIN_TRANSPORT, GOBP_ESTABLISHMENT_OF_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOMF_GTPASE_BINDING, GOBP_NUCLEAR_TRANSPORT, GOBP_PROTEIN_LOCALIZATION_TO_ORGANELLE, GOBP_NLS_BEARING_PROTEIN_IMPORT_INTO_NUCLEUS, GOBP_NUCLEAR_EXPORT, ACEVEDO_METHYLATED_IN_LIVER_CANCER_DN, GOBP_PROTEIN_LOCALIZATION_TO_NUCLEUS, chr2q14, GOCC_NUCLEAR_ENVELOPE, GOCC_NUCLEAR_PORE, GOMF_ACYLTRANSFERASE_ACTIVITY, GOMF_SUMO_TRANSFERASE_ACTIVITY, GOMF_AMINOACYLTRANSFERASE_ACTIVITY

GO Biological Process (2): NLS-bearing protein import into nucleus (GO:0006607), intracellular transport (GO:0046907)

GO Molecular Function (3): small GTPase binding (GO:0031267), GTPase activator activity (GO:0005096), protein binding (GO:0005515)

GO Cellular Component (2): nuclear pore (GO:0005643), cytoplasm (GO:0005737)

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
intracellular anatomical structure2
protein import into nucleus1
transport1
cellular localization1
establishment of localization in cell1
GTPase binding1
GTPase activity1
enzyme activator activity1
GTPase regulator activity1
binding1
nuclear envelope1
nuclear protein-containing complex1
cellular anatomical structure1

Protein interactions and networks

STRING

1624 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
RGPD8GRIP1Q9Y3R0855
RGPD8GOLGA4Q13439673
RGPD8GOLGA1Q92805671
RGPD8GCC1Q96CN9512
RGPD8M0QZ92M0QZ92418
RGPD8GCC2Q8IWJ2405
RGPD8RNASE4P34096398
RGPD8SYS1Q8N2H4315
RGPD8RUSC1Q9BVN2311
RGPD8ARFIP2P53365304
RGPD8CCDC186Q7Z3E2304
RGPD8RUNDC3AQ59EK9298
RGPD8MON2Q7Z3U7287
RGPD8ARFRP1Q13795269
RGPD8GBF1Q92538260

IntAct

103 interactions, top by confidence:

ABTypeScore
UCHL5PSMD11psi-mi:“MI:0914”(association)0.840
CENPSCENPXpsi-mi:“MI:0914”(association)0.810
EXOC3EXOC5psi-mi:“MI:0914”(association)0.790
NUP50KPNA3psi-mi:“MI:0914”(association)0.780
PSMD13PSMD11psi-mi:“MI:0914”(association)0.750
PSMC5PSMD11psi-mi:“MI:0914”(association)0.730
PSMD2PSMD11psi-mi:“MI:0914”(association)0.730
FAM136ARBFOX3psi-mi:“MI:0914”(association)0.640
NEMP1RGPD8psi-mi:“MI:0914”(association)0.640
RANRGPD8psi-mi:“MI:0914”(association)0.640
B2MNEMP1psi-mi:“MI:0914”(association)0.640
MIA2RGPD8psi-mi:“MI:0914”(association)0.640
KPNB1POM121Cpsi-mi:“MI:0914”(association)0.530
RANNEMP2psi-mi:“MI:0914”(association)0.530
MIA2RGPD3psi-mi:“MI:0914”(association)0.530
AKIRIN2RGPD3psi-mi:“MI:0914”(association)0.530
LGALS3BPRGPD8psi-mi:“MI:0914”(association)0.530
IER2KPNA3psi-mi:“MI:0914”(association)0.530
MLLT6RGPD8psi-mi:“MI:0914”(association)0.530
TSKSRGPD8psi-mi:“MI:0914”(association)0.530
DISC1AP4M1psi-mi:“MI:0914”(association)0.530

BioGRID (105): RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS), RGPD8 (Affinity Capture-MS)

ESM2 similar proteins: A0A0B4K7J2, A1ZAK1, A6NKT7, F4J8D3, G5ED39, H2QII6, O01510, O14715, O48767, P0DJD0, P0DJD1, P12798, P33144, P40358, P42286, P49792, Q00416, Q0IEK6, Q18508, Q18892, Q20937, Q291E4, Q2U639, Q4WVM7, Q5B8K7, Q61CW2, Q61WP7, Q6C9G0, Q6CXL5, Q6FUS3, Q6FVG5, Q70PP2, Q751J3, Q754V0, Q759B7, Q759Y1, Q75B70, Q75CM2, Q7TSH2, Q7Z3J3

Diamond homologs: A0A0B4K7J2, A6NKT7, E9Q3G8, H2QII6, O14715, P0DJD0, P0DJD1, P34022, P40517, P41920, P43487, P92985, Q09717, Q3T0M7, Q54KD9, Q7Z3J3, Q8RWG8, Q99666, Q9C829, Q9LMK7, Q9USL4, D3ZZL9, P32499, P34562, P48820, P49792, Q8CHG3, Q8IWJ2, Q9ERU9, G0S8I1, Q09146, Q86VV4, A0A075B759, A0A075B767, A0A0B4J2A2, A0A0R0H9T5, A4FV72, D4AY02, F5H284, O00060

SIGNOR signaling

0 interactions.

Enriched among interaction partners

Reactome pathways and GO biological processes over-represented among this gene’s 100 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.

Reactome pathways:

PathwayPartnersFoldFDR
Nuclear import of Rev protein1063.4×7e-14
Rev-mediated nuclear export of HIV RNA1059.9×7e-14
NEP/NS2 Interacts with the Cellular Export Machinery958.8×1e-12
NS1 Mediated Effects on Host Pathways1053.9×2e-13
Transport of Ribonucleoproteins into the Host Nucleus853.9×7e-11
IPs transport between nucleus and cytosol750.3×2e-09
IP3 and IP4 transport between cytosol and nucleus750.3×2e-09
IP6 and IP7 transport between cytosol and nucleus750.3×2e-09

GO biological processes:

GO termPartnersFoldFDR
NLS-bearing protein import into nucleus547.2×9e-06
nucleocytoplasmic transport732.3×4e-07
protein import into nucleus1220.3×3e-10
mRNA transport618.6×1e-04
mRNA export from nucleus517.4×8e-04
exocytosis610.7×1e-03
chromosome segregation510.2×6e-03
cell division94.9×5e-03

Disease & clinical

Clinical variants and AI predictions

ClinVar

200 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic2
Likely pathogenic0
Uncertain significance178
Likely benign16
Benign1

Top pathogenic / likely-pathogenic (2)

Variant IDHGVSClassification
1807763GRCh37/hg19 2q13(chr2:111369264-113142794)x1Pathogenic
2580318GRCh37/hg19 2q13(chr2:111335152-113127204)x1Pathogenic

SpliceAI

3151 predictions. Top by Δscore:

VariantEffectΔscore
2:112370222:G:GCacceptor_gain1.0000
2:112378040:T:Adonor_gain1.0000
2:112378049:CCA:Cdonor_loss1.0000
2:112378050:CA:Cdonor_loss1.0000
2:112378258:G:GCacceptor_gain1.0000
2:112378261:T:Cacceptor_gain1.0000
2:112378261:T:TCacceptor_gain1.0000
2:112380818:TCTCA:Tdonor_loss1.0000
2:112380819:CTCA:Cdonor_loss1.0000
2:112380820:TCA:Tdonor_loss1.0000
2:112380821:CA:Cdonor_loss1.0000
2:112380823:CC:Cdonor_loss1.0000
2:112390962:ATT:Adonor_gain1.0000
2:112390964:T:TAdonor_gain1.0000
2:112391070:C:CCacceptor_gain1.0000
2:112394613:CTCA:Cdonor_loss1.0000
2:112394614:TCA:Tdonor_loss1.0000
2:112394615:CAC:Cdonor_loss1.0000
2:112394616:A:ATdonor_loss1.0000
2:112394617:C:Adonor_loss1.0000
2:112394750:CTTT:Cacceptor_gain1.0000
2:112394754:C:CCacceptor_gain1.0000
2:112394757:T:TCacceptor_gain1.0000
2:112397917:CTTA:Cdonor_loss1.0000
2:112397918:TTA:Tdonor_loss1.0000
2:112397919:TA:Tdonor_loss1.0000
2:112397920:A:ACdonor_gain1.0000
2:112397920:AC:Adonor_gain1.0000
2:112397921:C:CAdonor_gain1.0000
2:112397921:CC:Cdonor_gain1.0000

AlphaMissense

11594 scored. Top likely-pathogenic:

VariantProtein changeam_pathogenicity
2:112422600:C:TG67D0.998
2:112422601:C:GG67R0.998
2:112388663:A:GW1428R0.997
2:112388663:A:TW1428R0.997
2:112389554:A:GW1131R0.996
2:112389554:A:TW1131R0.996
2:112424246:G:TA45D0.996
2:112424282:G:TA33E0.996
2:112389469:A:GF1159S0.995
2:112389495:A:CF1150L0.995
2:112389495:A:TF1150L0.995
2:112389496:A:GF1150S0.995
2:112389497:A:GF1150L0.995
2:112422004:C:GA121P0.995
2:112422063:G:TA101E0.995
2:112422064:C:GA101P0.995
2:112422553:A:CY83D0.995
2:112422565:C:GA79P0.995
2:112422603:A:GL66P0.995
2:112389468:G:CF1159L0.994
2:112389468:G:TF1159L0.994
2:112389470:A:GF1159L0.994
2:112422564:G:TA79D0.994
2:112422594:A:GL69P0.994
2:112388558:C:GA1463P0.993
2:112388611:A:TV1445D0.993
2:112389552:C:AW1131C0.993
2:112389552:C:GW1131C0.993
2:112401807:A:GW440R0.993
2:112401807:A:TW440R0.993

dbSNP variants (sampled 300 via entrez): RS1000043652 (2:112430520 C>A), RS1000097726 (2:112380412 G>A), RS1000138102 (2:112430789 C>A,T), RS1000203792 (2:112413703 T>C), RS1000382912 (2:112369895 T>C), RS1000503754 (2:112422716 C>G,T), RS1000598025 (2:112423952 G>A,C), RS1000705052 (2:112373638 C>T), RS1000717430 (2:112414777 T>C,G), RS1001116073 (2:112375057 T>C), RS1001608630 (2:112392788 A>C), RS1002337606 (2:112434418 G>A), RS1002384576 (2:112429289 C>A,T), RS1002482588 (2:112429618 C>T), RS1002734103 (2:112434261 CG>C)

Disease associations

OMIM: gene MIM:602752 | disease phenotypes:

GenCC curated gene-disease

Mondo (1): 2q13 microdeletion syndrome (MONDO:0975887)

Orphanet (1): 2q13 microdeletion syndrome (Orphanet:684742)

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

13 total (human), top 13 by PubMed support.

ChemicalActions (top 5)PubMed papers
GSK-J4increases expression1
triphenyl phosphateaffects expression1
beta-lapachoneincreases expression1
erucylphospho-N,N,N-trimethylpropylammoniumincreases expression1
Benzo(a)pyreneaffects methylation, increases methylation1
Cadmiumincreases abundance, increases expression1
Dimethyl Sulfoxideincreases expression1
Doxorubicindecreases expression1
Seleniumaffects cotreatment, decreases expression1
Valproic Acidincreases methylation1
Vitamin Eaffects cotreatment, decreases expression1
Asbestos, Crocidolitedecreases expression1
Cadmium Chlorideincreases abundance, increases expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

  • Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): 2q13 microdeletion syndrome